Endothelial progenitor cells: diagnostic and therapeutic considerations
Abstract
Endothelial progenitor cells (EPCs) may be defined as adherent cells derived from peripheral blood‐ or bone marrow‐derived mononuclear cells demonstrating acLDL uptake and isolectin‐binding capacity. The number of circulating EPCs inversely correlates with the number of cardiovascular risk factors and is reduced in cardiovascular disease. This measurement may therefore serves as a surrogate marker for cardiovascular disease risk. EPC numbers can be modified by various means. However, the effectiveness of risk‐factor modification on EPC number and function is currently unknown. Furthermore, EPCs may be used as a potential therapy for a variety of vascular disease states including ischaemia, restenosis and pulmonary hypertension. This review provides an update on multiple factors that affect EPC number as well as highlighting the potential use of EPCs as a novel marker of vascular dysfunction. Furthermore, potential gene‐ and/or EPC‐based approaches to a number of vascular disease states are explored. BioEssays 28: 261–270, 2006.Keywords
This publication has 95 references indexed in Scilit:
- Stimulation of Endothelial Progenitor CellsHypertension, 2005
- Endothelial Progenitor Cells During Cerebrovascular DiseaseStroke, 2005
- Hepatocyte growth factor induces angiogenesis in injured lungs through mobilizing endothelial progenitor cellsBiochemical and Biophysical Research Communications, 2004
- Rapamycin inhibits proliferation and differentiation of human endothelial progenitor cells in vitroExperimental Cell Research, 2004
- Adenoviral mediated gene transfer of PDGF‐B enhances wound healing in type I and type II diabetic woundsWound Repair and Regeneration, 2004
- C-reactive protein impairs angiogenic functions and decreases the secretion of arteriogenic chemo-cytokines in human endothelial progenitor cellsBiochemical and Biophysical Research Communications, 2004
- Surgical injury induces the mobilization of endothelial progenitor cellsSurgery, 2004
- Serum Derived from Multiple Trauma Patients Promotes the Differentiation of Endothelial Progenitor Cells In Vitro: Possible Role of Transforming Growth Factor-??1 and Vascular Endothelial Growth Factor165Shock, 2004
- Circulating endothelial progenitor cells are reduced in hemodialysis patientsCurrent Medical Research and Opinion, 2003
- Origins of circulating endothelial cells and endothelial outgrowth from bloodJournal of Clinical Investigation, 2000